Journal article · 2025 · Open access

Pathological Mechanism of Alzheimer's Disease, Progress in Drug Development and Future Prospects

Wenzhuo Chen

Highlights in Science Engineering and Technology, 144, 255–262 · Published 27 June 2025 · DOI 10.54097/epbvd190

Free PDFView at the publisherCite this paper

In brief

“Pathological Mechanism of Alzheimer's Disease, Progress in Drug Development and Future Prospects” is a 2025 journal article by Wenzhuo Chen, published in Highlights in Science Engineering and Technology. OpenAlex counts 0 citations as of 15 November 2026. It is open access under a CC BY-NC licence: the full text is free to read at Highlights in Science Engineering and Technology.

Citations
0
References
28
Authors
1

Abstract

Alzheimer's disease (AD) is the main cause of dementia. Its complex pathological mechanisms and multifactorial characteristics make the development of treatments face great challenges. This article reviews the origin of AD, symptom treatment drugs, pathological mechanism research, drug development progress and prevention strategies, and analyzes the limitations of current clinical applications and future development prospects. The study reviewed the historical discovery of AD, especially the genetic decoding of early-onset AD (EOAD), and explored key pathogenic genes such as APP, PSEN1, and PSEN2 and their role in the Aβ cascade hypothesis. In addition, this article summarizes the development of AD therapeutic drugs, including symptomatic treatment drugs such as cholinesterase inhibitors and memantine, as well as the progress of targeted therapy based on Aβ and Tau proteins in recent years. Although new antibody drugs such as aducanumab and lencanumab have been approved for marketing, their clinical efficacy is still controversial, and their high cost and potential side effects limit their widespread application. At present, AD research is facing the challenge of theoretical hypotheses and the exploration of new therapies. The future development direction may involve more accurate early diagnosis, biomarker screening and personalized treatment strategies, in order to improve the treatment effect and improve the quality of life of patients.

Cite this paper

Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.

APA 7

Chen, W. (2025). Pathological Mechanism of Alzheimer's Disease, Progress in Drug Development and Future Prospects. Highlights in Science Engineering and Technology, 144, 255–262. https://doi.org/10.54097/epbvd190

MLA 9

Chen, Wenzhuo. “Pathological Mechanism of Alzheimer's Disease, Progress in Drug Development and Future Prospects.” Highlights in Science Engineering and Technology, vol. 144, 2025, pp. 255–262. https://doi.org/10.54097/epbvd190.

Chicago

Chen, Wenzhuo. 2025. “Pathological Mechanism of Alzheimer's Disease, Progress in Drug Development and Future Prospects.” Highlights in Science Engineering and Technology 144: 255–262. https://doi.org/10.54097/epbvd190.

Harvard

Chen, W. (2025) ‘Pathological Mechanism of Alzheimer's Disease, Progress in Drug Development and Future Prospects’, Highlights in Science Engineering and Technology, 144, pp. 255–262. doi:10.54097/epbvd190.

IEEE

W. Chen, “Pathological Mechanism of Alzheimer's Disease, Progress in Drug Development and Future Prospects,” Highlights in Science Engineering and Technology, vol. 144, pp. 255–262, 2025, doi: 10.54097/epbvd190.

BibTeX

@article{chen2025pathological,
  title     = {{Pathological Mechanism of Alzheimer's Disease, Progress in Drug Development and Future Prospects}},
  author    = {Chen, Wenzhuo},
  journal   = {Highlights in Science Engineering and Technology},
  year      = {2025},
  volume    = {144},
  pages     = {255--262},
  doi       = {10.54097/epbvd190},
  url       = {https://doi.org/10.54097/epbvd190}
}

Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)

Topic and keywords

Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments

  • Alzheimer's disease
  • pathophysiological mechanisms
  • drug development
  • APP
  • presenilin 1
  • presenilin 2
  • cholinesterase inhibitors
  • memantine

Work with this paper

Most-cited papers in Neuroscience

All highly cited Neuroscience papers

Questions about this paper

How do I cite this paper in APA style?

Chen, W. (2025). Pathological Mechanism of Alzheimer's Disease, Progress in Drug Development and Future Prospects. Highlights in Science Engineering and Technology, 144, 255–262. https://doi.org/10.54097/epbvd190

How many times has this paper been cited?

0 times, according to OpenAlex on 15 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.

Is this paper free to read?

Yes. It is open access: read the free full text at Highlights in Science Engineering and Technology.

Who wrote this paper?

Wenzhuo Chen.

What is the DOI of this paper?

10.54097/epbvd190. The permanent link is https://doi.org/10.54097/epbvd190.

Bibliographic data from OpenAlex (CC0), last checked 15 November 2026. ResearchGuru does not host this paper; the links go to the publisher or the repository that does.